Business

The Food and Drug Administration (FDA) has granted accelerated approval to Biogen’s new drug, Tofersen, for treating a rare and aggressive form of amyotrophic lateral sclerosis (ALS). The approval was granted as Tofersen has filled an unmet medical need for serious conditions. However, Biogen and its co-developer Ionis must further study Tofersen and verify its
McDonald’s recently reported its Q1 earnings, which exceeded Wall Street expectations as the fast-food giant’s customers continued to purchase popular items like Big Macs and Shamrock Shakes. However, the company’s executives did express concerns over a possible recession looming in the United States and Europe, reiterating similar warnings from the previous quarter. McDonald’s customers in